Eur Rev Med Pharmacol Sci 2022; 26 (16): 5844-5856

DOI: 10.26355/eurrev_202208_29524

Regional and annual patterns in respiratory virus co-infection etiologies and antibiotic prescriptions for pediatric mycoplasma pneumoniae pneumonia

M. Sung, H.-J. Choi, M.-H. Lee, J.-Y. Lee, H.-B. Kim, Y.-M. Ahn, J.-K. Kim, H.-Y. Kim, S.-S. Jung, M. Kim, E.-K. Kang, E.-A. Yang, S.-J. Lee, Y. Park, J.-H. Seo, E. Lee, E.-S. Yang, K.-S. Park, M. Shin, H.-L. Chung, Y.-Y. Jang, B.-S. Choi, H. Kim, J.-A. Jung, S.-T. Yu, E.-J. Roh, E.-S. Lee, J.-T. Kim, B.-S. Kim, Y.-H. Hwang, I.-S. Sol, H.-J. Yang, M.-Y. Han, H.-Y. Yew, H.-M. Cho, H.-Y. Kim, Y.-H. Hn, D.-H. Im, K. Hwang, J. Yoo, S.-O. Jung, Y.-H. Jeon, J.-Y. Shim, E.-H. Chung

Department of Pediatrics, Soonchunhyang University Gumi Hospital, Gumi, Republic of Korea. ehchung@cnu.ac.kr


OBJECTIVE: Mycoplasma pneumoniae (M. pneumoniae) pneumonia is the second-most common cause of community-acquired pneumonia (CAP). This study aimed at investigating into the prevalence of macrolide-resistant M. pneumoniae (MRMP) with respiratory virus co-infection and the antibiotic prescriptions in children with CAP in four provinces in Korea, and to assess the variations in the findings across regions and throughout the year.

PATIENTS AND METHODS: This prospective study was conducted in 29 hospitals in Korea between July 2018 and June 2020. Among the enrolled 1,063 children with CAP, all 451 patients with M. pneumoniae underwent PCR assays of M. pneumoniae and respiratory viruses, and the presence of point mutations of residues 2063 and 2064 was evaluated.

RESULTS: Gwangju-Honam (88.6%) showed the highest prevalence of MRMP pneumonia, while Daejeon-Chungcheong (71.3%) showed the lowest, although the differences in prevalence were not significant (p=0.074). Co-infection of M. pneumoniae pneumonia and respiratory virus was observed in 206 patients (45.4%), and rhinovirus co-infection (101 children; 22.2%) was the most frequent. The prevalence of MRMP pneumonia with respiratory virus co-infection and the antibiotic prescriptions differed significantly among the four provinces (p < 0.05). The monthly rate of MRMP pneumonia cases among all cases of M. pneumoniae pneumonia and tetracycline or quinolone prescriptions did not differ significantly among the four regions (trend p > 0.05) during the study period.

CONCLUSIONS: The prevalence of M. pneumoniae pneumonia with virus co-infection and antibiotic prescriptions could differ according to region, although the MRMP pneumonia rate showed no difference within Korea.

Free PDF Download

To cite this article

M. Sung, H.-J. Choi, M.-H. Lee, J.-Y. Lee, H.-B. Kim, Y.-M. Ahn, J.-K. Kim, H.-Y. Kim, S.-S. Jung, M. Kim, E.-K. Kang, E.-A. Yang, S.-J. Lee, Y. Park, J.-H. Seo, E. Lee, E.-S. Yang, K.-S. Park, M. Shin, H.-L. Chung, Y.-Y. Jang, B.-S. Choi, H. Kim, J.-A. Jung, S.-T. Yu, E.-J. Roh, E.-S. Lee, J.-T. Kim, B.-S. Kim, Y.-H. Hwang, I.-S. Sol, H.-J. Yang, M.-Y. Han, H.-Y. Yew, H.-M. Cho, H.-Y. Kim, Y.-H. Hn, D.-H. Im, K. Hwang, J. Yoo, S.-O. Jung, Y.-H. Jeon, J.-Y. Shim, E.-H. Chung
Regional and annual patterns in respiratory virus co-infection etiologies and antibiotic prescriptions for pediatric mycoplasma pneumoniae pneumonia

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 16
Pages: 5844-5856
DOI: 10.26355/eurrev_202208_29524